Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors.
- DOI
- 10.1111/bpa.70137
- Published
- 2026 Sep 2
- Container
- Brain pathology (Zurich, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bpa.70137,
title = {Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors.},
author = {Dahnoun J and van Kempen LC and Koljenović S and Op de Beeck K and Menovsky T and Feyen B and Ahmed M and Sieben A and Zwaenepoel K},
year = {2026},
journal = {Brain pathology (Zurich, Switzerland)},
doi = {10.1111/bpa.70137},
url = {https://doi.org/10.1111/bpa.70137}
}RIS
TY - JOUR TI - Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors. AU - Dahnoun J AU - van Kempen LC AU - Koljenović S AU - Op de Beeck K AU - Menovsky T AU - Feyen B AU - Ahmed M AU - Sieben A AU - Zwaenepoel K PY - 2026 JO - Brain pathology (Zurich, Switzerland) DO - 10.1111/bpa.70137 UR - https://doi.org/10.1111/bpa.70137 ER -
APA
J, D., LC, V. K., S, K., K, O. D. B., T, M., B, F., M, A., A, S., & K, Z. (2026). Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors.. Brain pathology (Zurich, Switzerland). https://doi.org/10.1111/bpa.70137
Source records
- pubmed · retrieved 2026-09-25T22:48:52.033Z